Treatments for Hemophilia

Below is a listing of treatments and therapies for hemophilia. Click on one to read more information or connect with others currently using it.

View:
  • Novoeight (Antihemophilic factor [recombinant])

    Overview
    Novoeight is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Novoeight can also be used for perioperative (before,... read more

  • NovoSeven RT (Coagulation factor VIIa [recombinant])

    Overview
    NovoSeven RT is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A or B. Typically, Novo... read more

  • Nuwiq (Human coagulation factor VIII [rDNA], simoctocog alfa)

    Overview
    Nuwiq is approved by the Food and Drug Administration (FDA) to treat and prevent bleeding episodes in children and adults with hemophilia A (congenital factor VIII deficiency). The technical name of N... read more

  • Obizur (Antihemophilic factor [Recombinant], porcine sequence)

    Overview
    Obizur is approved by the Food and Drug Administration (FDA) to control bleeding episodes in adults with acquired hemophilia. The technical name of Obizur is Antihemophilic factor (recombinant), porci... read more

  • Physical therapy

    Overview
    Physical therapy can help keep your joints and muscles working properly. Physical therapy can also rehabilitate joints after a bleed. Better fitness can help improve balance and strength and cut down ... read more

  • Profilnine (Factor IX complex [human])

    Overview
    Profilnine is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Profilnine is Factor IX complex (human).

    Profiln... read more

  • Proplex-T (Factor IX complex, heat treated [human])

    Overview
    Proplex-T is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. Proplex-T may also be used for perioperative (before, during, and after sur... read more

  • Recombinate (Antihemophilic factor [recombinant])

    Overview
    Recombinate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Recombinate can also be used for perioperative (bef... read more

  • ReFacto (Antihemophilic factor [recombinant])

    Overview
    ReFacto is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. ReFacto can also be used for perioperative (before, dur... read more

  • RiaSTAP (Fibrinogen concentrate [human])

    Overview
    RiaSTAP is approved by the Food and Drug Administration (FDA) to treat acute bleeding episodes in people with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. The te... read more

  • Rixubis (Coagulation factor IX [recombinant])

    Overview
    Rixubis is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. Rixubis can also be used for perioperative (before, dur... read more

  • Stimate (Desmopressin)

    Overview
    Stimate is approved by the Food and Drug Administration (FDA) to stop bleeding episodes in children and adults with mild hemophilia A or mild to moderate von Willebrand’s Disease. Stimate is also know... read more

  • Vonvendi (von Willebrand factor [recombinant])

    Overview
    Vonvendi is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in adults with von Willebrand disease. The technical name of Vonvendi is von Wil... read more

  • Wilate (von Willebrand factor/Coagulation factor VIII complex [human])

    Overview
    Wilate is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in children and adults with von Willebrand disease. Wilate can also be used for pe... read more

  • Xyntha (Antihemophilic factor [recombinant])

    Overview
    Xyntha is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Xyntha can also be used for perioperative (before, durin... read more

Continue with Facebook
Sign up with your email
Already a Member? Log in
×

Welcome back!

Log in to gain access to the thousands of comments being shared on MyHemophiliaTeam.

log in
×